Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07228039 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ESP Blocks for Posterior Spinal Fusion

Name: ESP Blocks for Posterior Spinal Fusion — clinical trial record (NCT07228039)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 4

SponsorDuke University

Started2027-10

View on ClinicalTrials.gov ↗

Amendment history

2026-08-25

Study Status v3

Start date2026-07→2027-10

2026-06-17

Study Status v2

Start date2026-05→2026-07

2026-05-07

Study Status, Outcome Measures v1

Start date2026-01→2026-05

Secondary endpointsdetails revised at 1 of 5 entries

2025-11-12

Original filing

Duke University

455 trials monitored

See 53 trials at risk

This prospective randomized double-blind study evaluates the efficacy of erector spinae plane (ESP) blocks on postoperative pain in patients undergoing cervical or lumbar posterior spinal fusion. Patients will receive either 0.5% bupivacaine plus liposomal bupivacaine or 0.5% plain bupivacaine. Outcomes include opioid consumption over 72 hours, pain scores, length of stay, and time to ambulation.

Trial Details

NCT Number	NCT07228039
Lead Sponsor	Duke University
Conditions	Postoperative Pain
Enrollment	75 participants
Start Date	2027-10
Primary Completion	2028-01 (estimated)
Study Completion	2028-01 (estimated)
Updated on ClinicalTrials.gov	2026-08-27